Leading science, pioneering therapies

Redirecting cell fate group publications

2015

Wilmut I, Bai Y, Taylor J.  2015.  Somatic cell nuclear transfer: origins, the present position and future opportunitiesPhilosophical Transactions of the Royal Society B: Biological Sciences. 370363394399(1680):20140366.
Hyllner J, Mason C, Wilmut I.  2015.  Cells: from Robert Hooke to cell therapy - a 350 year journeyPhilos Trans R Soc Lond B Biol Sci. 370(1680):20150320.
Wilmut I, Leslie S, Martin NG, Peschanski M, Rao M, Trounson A, Turner D, Turner ML, Yamanaka S, Taylor CJ.  2015.  Development of a global network of induced pluripotent stem cell haplobanksRegenerative Medicine. 10(3):235-238.

2014

Andrews PW, Cavanagro J, Deans R, Feigel E, Horowitz E, Keating A, Rao M, Turner M, Wilmut I, Yamanaka S.  2014.  Harmonizing standards for producing clinical-grade therapies from pluripotent stem cellsNature Biotechnology. 32(8):724-726.

2013

O'Connor T, Wilmut I, Taylor J.  2013.  Quantitative evaluation of reference genes for real-time PCR during in vitro maturation of ovine oocytes.Reprod Domest Anim. 48(3):477-83.
Turner ML, Leslie S, Martin NG, Peschanski M, Rao M, Taylor CJ, Trounson A, Turner D, Yamanaka S, Wilmut I.  2013.  Toward the development of a global induced pluripotent stem cell library.Cell Stem Cell. 13(4):382-4.
Borooah S, Phillips MJ, Bilican B, Wright AF, Wilmut I, Chandran S, Gamm D, Dhillon B.  2013.  Using human induced pluripotent stem cells to treat retinal disease.Prog Retin Eye Res. 37:163-81.
Serio A, Bilican B, Barmada SJ, Ando DMichael, Zhao C, Siller R, Burr K, Haghi G, Story D, Nishimura AL et al..  2013.  Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy.Proc Natl Acad Sci U S A. 110(12):4697-702.

2012

Wilmut I.  2012.  Retrospective. Keith Campbell (1954-2012).Science. 338(6114):1553.
Bilican B, Serio A, Barmada SJ, Nishimura AL, Sullivan G, Carrasco M, Phatnani HP, Puddifoot CA, Story D, Fletcher J et al..  2012.  Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability.Proc Natl Acad Sci U S A. 109(15):5803-8.
Zhou W, Hannoun Z, Jaffray E, Medine C.N, Black JR, Greenhough S, Zhu L, Ross JA, Forbes SJ, Wilmut I et al..  2012.  SUMOylation of HNF4α regulates protein stability and hepatocyte function.J Cell Sci. 125(Pt 15):3630-5.

2011

Ruzov A, Tsenkina Y, Serio A, Dudnakova T, Fletcher J, Bai Y, Chebotareva T, Pells S, Hannoun Z, Sullivan G et al..  2011.  Lineage-specific distribution of high levels of genomic 5-hydroxymethylcytosine in mammalian development.Cell Res. 21(9):1332-42.
Wilmut I, Wongtawan T, Quigley M, Sullivan G.  2011.  Biomedical and social contributions to sustainability.Philos Trans A Math Phys Eng Sci. 369(1942):1730-47.
Chebotareva T, Taylor J, Mullins JJ, Wilmut I.  2011.  Rat eggs cannot wait: Spontaneous exit from meiotic metaphase-II arrest.Mol Reprod Dev. 78(10-11):795-807.
Gurdon JB, Wilmut I.  2011.  Nuclear transfer to eggs and oocytes.Cold Spring Harb Perspect Biol. 3(6)
Wongtawan T, Taylor JE, Lawson KA, Wilmut I, Pennings S.  2011.  Histone H4K20me3 and HP1α are late heterochromatin markers in development, but present in undifferentiated embryonic stem cells.J Cell Sci. 124(Pt 11):1878-90.
Wilmut I, Sullivan G, Chambers I.  2011.  The evolving biology of cell reprogramming.Philos Trans R Soc Lond B Biol Sci. 366(1575):2183-97.

2010

Wilmut I.  2010.  A new title and a new focus: Cellular Reprogramming.Cell Reprogram. 12(1):1.
Sullivan G, Bai Y, Fletcher J, Wilmut I.  2010.  Induced pluripotent stem cells: epigenetic memories and practical implications.Mol Hum Reprod. 16(12):880-5.

Pages